Prediction of mortality in hospitalized Egyptian patients with Coronavirus disease-2019: A multicenter retrospective study
Muhammad M Abdelghaffar, Dalia Omran, Ahmed Elgebaly, Eshak I Bahbah, Shimaa Afify, Mohamed Alsoda, Mohamed El-Shiekh, Enass S Elsayed, Soha S Shaaban, Samah Abdelhafez, Khaled Elkelany, Ayman A Eltayar, Omnia S Ali, Lamiaa Kamal, Ahmed M Heiba, Ahmad El Askary, Hend Ibrahim Shousha
PLOS ONE, doi:10.1371/journal.pone.0262348
We aimed to assess the epidemiological, clinical, and laboratory characteristics associated with mortality among hospitalized Egyptian patients with COVID-19. A multicenter, retrospective study was conducted on all polymerase chain reaction (PCR)-confirmed COVID-19 cases admitted through the period from April to July 2020. A generalized linear model was reconstructed with covariates based on predictor's statistical significance and clinically relevance. The odds ratio (OR) was calculated by using stepwise logistic regression modeling. A total of 3712 hospitalized patients were included; of them, 900 deaths were recorded (24.2%). Compared to survived patients, non-survived patients were more likely to be older than 60 years (65.7%), males (53.6%) diabetic (37.6%), hypertensive (37.2%), and had chronic renal insufficiency (9%). Non-survived patients were less likely to receive azithromycin (p <0.001), anticoagulants (p <0.001), and steroids (p <0.001). We found that age � 60 years old (OR = 2.82, 95% CI 2.05-3.86; p <0.0001), diabetes mellitus (
Supporting information S1
References
Boettler, Marjot, Newsome, Mondelli, Maticic et al., Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic, JHEP Rep,
doi:10.1016/j.jhepr.2020.100169
Cao, Li, Feng, Wan, Huang et al., Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations, Cell Discov,
doi:10.1038/s41421-020-0147-1
Chen, Klein, Garibaldi, Li, Wu et al., Aging in COVID-19: Vulnerability, immunity and intervention, Ageing Res Rev,
doi:10.1016/j.arr.2020.101205
Chen, Wu, Chen, Yang, Chen, Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study, BMJ,
doi:10.1136/bmj.m1091
Coperchini, Chiovato, Croce, Magri, Rotondi, The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system, Cytokine Growth Factor Rev,
doi:10.1016/j.cytogfr.2020.05.003
Cuker, Peyvandi, Coronavirus disease 2019 (COVID-19): Hypercoagulability
Docherty, Harrison, Green, Hardwick, Pius et al., Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study, BMJ,
doi:10.1136/bmj.m1985
Fung, Yuen, Ye, Chan, Jin, A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses, Emerg. Microbes Infect,
doi:10.1080/22221751.2020.1736644
Gebhard, Regitz-Zagrosek, Neuhauser, Morgan, Klein, Impact of sex and gender on COVID-19 outcomes in Europe, Biol Sex Differ,
doi:10.1186/s13293-020-00304-9
Griesbeck, Ziegler, Laffont, Smith, Chauveau et al., Sex differences in plasmacytoid dendritic cell levels of Irf5 drive higher Ifn-alpha production in women, J Immunol,
doi:10.4049/jimmunol.1501684
Guan, Ni, Hu, Liang, Ou et al., Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med,
doi:10.1056/NEJMoa2002032
Harrison, Fazio-Eynullayeva, Lane, Underhill, Lip, Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis, PLoS Med,
doi:10.1371/journal.pmed.1003321
Hoffmann, Kleine-Weber, Schroeder, Kru ¨ger, Herrler et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell,
doi:10.1016/j.cell.2020.02.052
Inciardi, Lupi, Zaccone, Italia, Raffo et al., Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19), JAMA Cardiol,
doi:10.1001/jamacardio.2020.1096
Klein, Pekosz, Park, Ursin, Shapiro et al., Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population, J Clin Invest,
doi:10.1172/JCI142004
Kragholm, Andersen, Gerds, Butt, Østergaard et al., Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19)-a Danish nationwide, register-based study, Clin Infect Dis,
doi:10.1093/cid/ciaa924
Lim, Bae, Kwon, Nauck, COVID-19 and diabetes mellitus: from pathophysiology to clinical management, Nat Rev Endocrinol,
doi:10.1038/s41574-020-00435-4
Mcbane Rd 2nd, Roldan, Niven, Pruthi, Franco et al., Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic, Mayo Clin Proc,
doi:10.1016/j.mayocp.2020.08.030
Middleton, Practical use of the Glasgow Coma Scale; a comprehensive narrative review of GCS methodology, Australas Emerg Nurs J,
doi:10.1016/j.aenj.2012.06.002
Nasiri, Haddadi, Tahvildari, Farsi, Arbabi et al., COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis, Front Med,
doi:10.3389/fmed.2020.00459
O'driscoll, Dos Santos, Wang, Cummings, Azman et al., Age-specific mortality and immunity patterns of SARS-CoV-2, Nature,
doi:10.1038/s41586-020-2918-0
Onder, Rezza, Brusaferro, Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy, JAMA,
doi:10.1001/jama.2020.4683
Peckham, De Gruijter, Raine, Radziszewska, Ciurtin et al., Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission, Nat Commun,
doi:10.1038/s41467-020-19741-6
Petrilli, Jones, Yang, Rajagopalan, Donnell et al., Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study, BMJ,
doi:10.1136/bmj.m1966
Richardson, Hirsch, Narasimhan, Crawford, Mcginn et al., Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area, JAMA,
doi:10.1001/jama.2020.6775
Singh, Khan, Liver Disease in United States: A Multi-Center Research Network Study
Tiwari, Khatib, Dixit, Rathore, Melinkeri et al., Anticoagulation in COVID-19: An Update, J Crit Care Med (,
doi:10.2478/jccm-2020-0033
Verity, Okell, Dorigatti, Winskill, Whittaker et al., Estimates of the severity of coronavirus disease 2019: a model-based analysis, Lancet Infect Dis,
doi:10.1016/S1473-3099%2820%2930243-7
Von Elm, Altman, Egger, Pocock, Gøtzsche et al., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies, Int J Surg,
doi:10.1016/j.ijsu.2014.07.013
Walker, Grint, Strongman, Eggo, Peppa et al., UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records, BMC Public Health,
doi:10.1186/s12889-021-10427-2
Williams, Mancia, Spiering, Rosei, Azizi et al., ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension, Eur Heart J,
doi:10.1093/eurheartj/ehy339
Worldometers, None
Wu, Mcgoogan, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention, JAMA,
doi:10.1001/jama.2020.2648
Xie, Ma, Tang, Liu, Severe COVID-19: A Review of Recent Progress with a Look toward the future, Front Public Health,
doi:10.3389/fpubh.2020.00189
Yang, Zheng, Gou, Pu, Chen et al., Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis, Int J Infect Dis,
doi:10.1016/j.ijid.2020.03.017
Zhang, Wu, Li, Zhao, Wang, Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality, Int J Antimicrob Agents,
doi:10.1016/j.ijantimicag.2020.105954
Zhang, Zhou, Zhu, Song, Feng et al., Immune phenotyping based on the neutrophil-tolymphocyte ratio and igg level predicts disease severity and outcome for patients with COVID-19, Front. Mol. Biosci,
doi:10.3389/fmolb.2020.00157
DOI record:
{
"DOI": "10.1371/journal.pone.0262348",
"ISSN": [
"1932-6203"
],
"URL": "http://dx.doi.org/10.1371/journal.pone.0262348",
"abstract": "<jats:p>We aimed to assess the epidemiological, clinical, and laboratory characteristics associated with mortality among hospitalized Egyptian patients with COVID-19. A multicenter, retrospective study was conducted on all polymerase chain reaction (PCR)-confirmed COVID-19 cases admitted through the period from April to July 2020. A generalized linear model was reconstructed with covariates based on predictor’s statistical significance and clinically relevance. The odds ratio (OR) was calculated by using stepwise logistic regression modeling. A total of 3712 hospitalized patients were included; of them, 900 deaths were recorded (24.2%). Compared to survived patients, non-survived patients were more likely to be older than 60 years (65.7%), males (53.6%) diabetic (37.6%), hypertensive (37.2%), and had chronic renal insufficiency (9%). Non-survived patients were less likely to receive azithromycin (p <0.001), anticoagulants (p <0.001), and steroids (p <0.001). We found that age ≥ 60 years old (OR = 2.82, 95% CI 2.05–3.86; p <0.0001), diabetes mellitus (OR = 1.58, 95% CI 1.14–2.19; p = 0.006), hypertension (OR = 1.69, 95% CI 1.22–2.36; p = 0.002), chronic renal insufficiency (OR = 3.15, 95% CI 1.84–5.38; p <0.0001), tachycardia (OR = 1.65, 95% CI 1.22–2.23; p <0.001), hypoxemia (OR = 5.69, 95% CI 4.05–7.98; p <0.0001), GCS <13 (OR 515.2, 95% CI 148.5–1786.9; p <0.0001), the use of therapeutic dose of anticoagulation (OR = 0.4, 95% CI 0.22–0.74, p = 0.003) and azithromycin (OR = 0.16, 95% CI 0.09–0.26; p <0.0001) were independent negative predictors of mortality. In conclusion, age >60 years, comorbidities, tachycardia, hypoxemia, and altered consciousness level are independent predictors of mortality among Egyptian hospitalized patients with COVID-19. On the other hand, the use of anticoagulants and azithromycin is associated with reduced mortality.</jats:p>",
"author": [
{
"affiliation": [],
"family": "AbdelGhaffar",
"given": "Muhammad M.",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-5513-6955",
"affiliation": [],
"authenticated-orcid": true,
"family": "Omran",
"given": "Dalia",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Elgebaly",
"given": "Ahmed",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bahbah",
"given": "Eshak I.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Afify",
"given": "Shimaa",
"sequence": "additional"
},
{
"affiliation": [],
"family": "AlSoda",
"given": "Mohamed",
"sequence": "additional"
},
{
"affiliation": [],
"family": "El-Shiekh",
"given": "Mohamed",
"sequence": "additional"
},
{
"affiliation": [],
"family": "ElSayed",
"given": "Enass S.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Shaaban",
"given": "Soha S.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "AbdelHafez",
"given": "Samah",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Elkelany",
"given": "Khaled",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Eltayar",
"given": "Ayman A.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ali",
"given": "Omnia S.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Kamal",
"given": "Lamiaa",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Heiba",
"given": "Ahmed M.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "El Askary",
"given": "Ahmad",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-0928-4738",
"affiliation": [],
"authenticated-orcid": true,
"family": "Shousha",
"given": "Hend Ibrahim",
"sequence": "additional"
}
],
"container-title": [
"PLOS ONE"
],
"content-domain": {
"crossmark-restriction": false,
"domain": [
"www.plosone.org"
]
},
"created": {
"date-parts": [
[
2022,
1,
11
]
],
"date-time": "2022-01-11T18:52:15Z",
"timestamp": 1641927135000
},
"deposited": {
"date-parts": [
[
2022,
1,
11
]
],
"date-time": "2022-01-11T18:52:47Z",
"timestamp": 1641927167000
},
"editor": [
{
"affiliation": [],
"family": "Mitra",
"given": "Prasenjit",
"sequence": "first"
}
],
"indexed": {
"date-parts": [
[
2022,
1,
12
]
],
"date-time": "2022-01-12T05:58:29Z",
"timestamp": 1641967109499
},
"is-referenced-by-count": 0,
"issn-type": [
{
"type": "electronic",
"value": "1932-6203"
}
],
"issue": "1",
"issued": {
"date-parts": [
[
2022,
1,
11
]
]
},
"journal-issue": {
"issue": "1",
"published-online": {
"date-parts": [
[
2022,
1,
11
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
1,
11
]
],
"date-time": "2022-01-11T00:00:00Z",
"timestamp": 1641859200000
}
}
],
"link": [
{
"URL": "https://dx.plos.org/10.1371/journal.pone.0262348",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "340",
"original-title": [],
"page": "e0262348",
"prefix": "10.1371",
"published": {
"date-parts": [
[
2022,
1,
11
]
]
},
"published-online": {
"date-parts": [
[
2022,
1,
11
]
]
},
"publisher": "Public Library of Science (PLoS)",
"reference": [
{
"DOI": "10.1016/S0140-6736(20)30183-5",
"article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.",
"author": "C Huang",
"doi-asserted-by": "crossref",
"first-page": "497",
"issue": "10223",
"journal-title": "Lancet.",
"key": "pone.0262348.ref001",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1016/j.cytogfr.2020.05.003",
"article-title": "The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system",
"author": "F Coperchini",
"doi-asserted-by": "crossref",
"first-page": "25",
"journal-title": "Cytokine Growth Factor Rev",
"key": "pone.0262348.ref002",
"volume": "53",
"year": "2020"
},
{
"DOI": "10.1016/j.ijantimicag.2020.105954",
"article-title": "Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality",
"author": "C Zhang",
"doi-asserted-by": "crossref",
"first-page": "105954",
"issue": "5",
"journal-title": "Int J Antimicrob Agents",
"key": "pone.0262348.ref003",
"volume": "55",
"year": "2020"
},
{
"DOI": "10.1001/jamacardio.2020.1096",
"article-title": "Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).",
"author": "RM Inciardi",
"doi-asserted-by": "crossref",
"first-page": "819",
"issue": "7",
"journal-title": "JAMA Cardiol. 2020",
"key": "pone.0262348.ref004",
"volume": "5"
},
{
"DOI": "10.3389/fpubh.2020.00189",
"article-title": "Severe COVID-19: A Review of Recent Progress with a Look toward the future",
"author": "P Xie",
"doi-asserted-by": "crossref",
"first-page": "189",
"journal-title": "Front Public Health",
"key": "pone.0262348.ref005",
"volume": "8",
"year": "2020"
},
{
"key": "pone.0262348.ref006",
"unstructured": "European Centre for Disease Prevention and Control. Situation update worldwide, as of week 1 2021. 2021. Available at: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases."
},
{
"DOI": "10.1056/NEJMoa2002032",
"article-title": "Clinical Characteristics of Coronavirus Disease 2019 in China",
"author": "WJ Guan",
"doi-asserted-by": "crossref",
"first-page": "1708",
"issue": "18",
"journal-title": "N Engl J Med",
"key": "pone.0262348.ref007",
"volume": "382",
"year": "2020"
},
{
"DOI": "10.1016/S1473-3099(20)30243-7",
"article-title": "Estimates of the severity of coronavirus disease 2019: a model-based analysis",
"author": "R Verity",
"doi-asserted-by": "crossref",
"first-page": "669",
"issue": "6",
"journal-title": "Lancet Infect Dis. 2020",
"key": "pone.0262348.ref008",
"volume": "20"
},
{
"DOI": "10.1038/s41421-020-0147-1",
"article-title": "Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations",
"author": "Y Cao",
"doi-asserted-by": "crossref",
"first-page": "11",
"journal-title": "Cell Discov",
"key": "pone.0262348.ref009",
"volume": "6",
"year": "2020"
},
{
"DOI": "10.20944/preprints202002.0258.v2",
"article-title": "Asians Do Not Exhibit Elevated Expression or Unique Genetic Polymorphisms for ACE2, the Cell-Entry Receptor of SARS-CoV-2",
"author": "Y Chen",
"doi-asserted-by": "crossref",
"key": "pone.0262348.ref010",
"year": "2020"
},
{
"DOI": "10.1016/j.arr.2020.101205",
"article-title": "Aging in COVID-19: Vulnerability, immunity and intervention",
"author": "Y Chen",
"doi-asserted-by": "crossref",
"first-page": "101205",
"journal-title": "Ageing Res Rev",
"key": "pone.0262348.ref011",
"volume": "65",
"year": "2021"
},
{
"DOI": "10.1186/s12889-021-10427-2",
"article-title": "UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records",
"author": "JL Walker",
"doi-asserted-by": "crossref",
"first-page": "484",
"issue": "1",
"journal-title": "BMC Public Health",
"key": "pone.0262348.ref012",
"volume": "21",
"year": "2021"
},
{
"DOI": "10.1186/s13293-020-00304-9",
"article-title": "Impact of sex and gender on COVID-19 outcomes in Europe",
"author": "C Gebhard",
"doi-asserted-by": "crossref",
"first-page": "29",
"journal-title": "Biol Sex Differ",
"key": "pone.0262348.ref013",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.4049/jimmunol.1501684",
"article-title": "Sex differences in plasmacytoid dendritic cell levels of Irf5 drive higher Ifn-alpha production in women",
"author": "M Griesbeck",
"doi-asserted-by": "crossref",
"first-page": "5327",
"issue": "11",
"journal-title": "J Immunol",
"key": "pone.0262348.ref014",
"volume": "195",
"year": "2015"
},
{
"key": "pone.0262348.ref015",
"unstructured": "World health organization, (2021 January 20), WHO Health Emergency Dashboard, WHO (COVID-19) Homepage retrieved from: https://covid19.who.int/region/emro/country/eg."
},
{
"DOI": "10.1016/j.ijsu.2014.07.013",
"article-title": "The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies",
"author": "STROBE Initiative",
"doi-asserted-by": "crossref",
"first-page": "1495",
"issue": "12",
"journal-title": "Int J Surg",
"key": "pone.0262348.ref016",
"volume": "12",
"year": "2014"
},
{
"article-title": "American Diabetes Association. Standards of medical care in diabetes—2011",
"first-page": "S11",
"issue": "Suppl 1",
"journal-title": "Diabetes Care",
"key": "pone.0262348.ref017",
"volume": "34",
"year": "2011"
},
{
"DOI": "10.1093/eurheartj/ehy339",
"article-title": "2018 ESC/ESH Guidelines for the management of arterial hypertension",
"author": "ESC Scientific Document Group",
"doi-asserted-by": "crossref",
"first-page": "3021",
"issue": "33",
"journal-title": "Eur Heart J",
"key": "pone.0262348.ref018",
"volume": "39",
"year": "2018"
},
{
"DOI": "10.1038/kisup.2012.77",
"article-title": "Summary of Recommendation Statements",
"doi-asserted-by": "crossref",
"first-page": "5",
"issue": "1",
"journal-title": "Kidney Int Suppl (2011).",
"key": "pone.0262348.ref019",
"volume": "3",
"year": "2013"
},
{
"DOI": "10.1016/j.aenj.2012.06.002",
"article-title": "Practical use of the Glasgow Coma Scale; a comprehensive narrative review of GCS methodology.",
"author": "PM Middleton",
"doi-asserted-by": "crossref",
"first-page": "170",
"issue": "3",
"journal-title": "Australas Emerg Nurs J.",
"key": "pone.0262348.ref020",
"volume": "15",
"year": "2012"
},
{
"key": "pone.0262348.ref021",
"unstructured": "Ministry of Health and Population, Egypt Management protocol for COVID-19 Patients Version 1.4 / 30th May 2020, Available at: https://www.elwatannews.com/data/iframe/pdf/17175200761591035127.pdf."
},
{
"key": "pone.0262348.ref022",
"unstructured": "Worldometers.info. 2020 October 8. Dover, Delaware, U.S.A. Retrieved from: https://www.worldometers.info/coronavirus/country/egypt/."
},
{
"DOI": "10.1001/jama.2020.2648",
"article-title": "Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention",
"author": "Z Wu",
"doi-asserted-by": "crossref",
"first-page": "1239",
"journal-title": "JAMA",
"key": "pone.0262348.ref023",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.1001/jama.2020.6775",
"article-title": "Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area",
"author": "S Richardson",
"doi-asserted-by": "crossref",
"first-page": "2052",
"issue": "20",
"journal-title": "JAMA",
"key": "pone.0262348.ref024",
"volume": "323",
"year": "2020"
},
{
"article-title": "Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.",
"author": "G Onder",
"first-page": "1775",
"journal-title": "JAMA",
"key": "pone.0262348.ref025",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.1038/s41586-020-2918-0",
"article-title": "Age-specific mortality and immunity patterns of SARS-CoV-2",
"author": "M O’Driscoll",
"doi-asserted-by": "crossref",
"first-page": "140",
"issue": "7844",
"journal-title": "Nature",
"key": "pone.0262348.ref026",
"volume": "590",
"year": "2021"
},
{
"DOI": "10.1016/j.exger.2017.10.024",
"article-title": "Age and immunity: what is “immunosenescence”?",
"author": "G Pawelec",
"doi-asserted-by": "crossref",
"first-page": "4",
"journal-title": "Exp. Gerontol",
"key": "pone.0262348.ref027",
"volume": "105",
"year": "2018"
},
{
"DOI": "10.1080/22221751.2020.1736644",
"article-title": "A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses",
"author": "SY Fung",
"doi-asserted-by": "crossref",
"first-page": "558",
"journal-title": "Emerg. Microbes Infect",
"key": "pone.0262348.ref028",
"volume": "9",
"year": "2020"
},
{
"DOI": "10.1172/JCI142004",
"article-title": "Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population",
"author": "SL Klein",
"doi-asserted-by": "crossref",
"first-page": "6141",
"issue": "11",
"journal-title": "J Clin Invest",
"key": "pone.0262348.ref029",
"volume": "130",
"year": "2020"
},
{
"DOI": "10.3389/fmolb.2020.00157",
"article-title": "Immune phenotyping based on the neutrophil-to-lymphocyte ratio and igg level predicts disease severity and outcome for patients with COVID-19",
"author": "B Zhang",
"doi-asserted-by": "crossref",
"first-page": "157",
"journal-title": "Front. Mol. Biosci",
"key": "pone.0262348.ref030",
"volume": "7",
"year": "2020"
},
{
"DOI": "10.3389/fmed.2020.00459",
"article-title": "COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis.",
"author": "MJ Nasiri",
"doi-asserted-by": "crossref",
"first-page": "459",
"journal-title": "Front Med (Lausanne).",
"key": "pone.0262348.ref031",
"volume": "7",
"year": "2020"
},
{
"DOI": "10.1136/bmj.m1966",
"article-title": "Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study",
"author": "CM Petrilli",
"doi-asserted-by": "crossref",
"first-page": "m1966",
"journal-title": "BMJ",
"key": "pone.0262348.ref032",
"volume": "369",
"year": "2020"
},
{
"article-title": "Association between male sex and outcomes of Coronavirus Disease 2019 (Covid-19)—a Danish nationwide, register-based study",
"author": "K Kragholm",
"first-page": "ciaa924",
"journal-title": "Clin Infect Dis",
"key": "pone.0262348.ref033",
"year": "2020"
},
{
"DOI": "10.1136/bmj.m1091",
"article-title": "Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study",
"author": "T Chen",
"doi-asserted-by": "crossref",
"first-page": "m1091",
"journal-title": "BMJ",
"key": "pone.0262348.ref034",
"volume": "368",
"year": "2020"
},
{
"DOI": "10.1016/j.cell.2020.02.052",
"article-title": "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor",
"author": "M Hoffmann",
"doi-asserted-by": "crossref",
"first-page": "271",
"issue": "2",
"journal-title": "Cell",
"key": "pone.0262348.ref035",
"volume": "181",
"year": "2020"
},
{
"DOI": "10.1038/s41467-020-19741-6",
"article-title": "Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission",
"author": "H Peckham",
"doi-asserted-by": "crossref",
"first-page": "6317",
"issue": "1",
"journal-title": "Nat Commun",
"key": "pone.0262348.ref036",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1136/bmj.m1985",
"article-title": "Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study",
"author": "AB Docherty",
"doi-asserted-by": "crossref",
"first-page": "m1985",
"journal-title": "BMJ",
"key": "pone.0262348.ref037",
"volume": "369",
"year": "2020"
},
{
"DOI": "10.1371/journal.pmed.1003321",
"article-title": "Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis",
"author": "SL Harrison",
"doi-asserted-by": "crossref",
"first-page": "e1003321",
"issue": "9",
"journal-title": "PLoS Med",
"key": "pone.0262348.ref038",
"volume": "17",
"year": "2020"
},
{
"DOI": "10.1016/j.ijid.2020.03.017",
"article-title": "Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis",
"author": "J Yang",
"doi-asserted-by": "crossref",
"first-page": "91",
"journal-title": "Int J Infect Dis",
"key": "pone.0262348.ref039",
"volume": "94",
"year": "2020"
},
{
"article-title": "Clinical Characteristics and Outcomes of COVID-19 among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study",
"author": "S Singh",
"first-page": "30585",
"issue": "20",
"journal-title": "Gastroenterology",
"key": "pone.0262348.ref040",
"year": "2020"
},
{
"DOI": "10.1016/j.jhepr.2020.100169",
"article-title": "Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic.",
"author": "T Boettler",
"doi-asserted-by": "crossref",
"first-page": "100169",
"issue": "5",
"journal-title": "JHEP Rep",
"key": "pone.0262348.ref041",
"volume": "2",
"year": "2020"
},
{
"DOI": "10.1038/s41574-020-00435-4",
"article-title": "COVID-19 and diabetes mellitus: from pathophysiology to clinical management",
"author": "S Lim",
"doi-asserted-by": "crossref",
"first-page": "11",
"issue": "1",
"journal-title": "Nat Rev Endocrinol",
"key": "pone.0262348.ref042",
"volume": "17",
"year": "2021"
},
{
"DOI": "10.1016/j.mayocp.2020.08.030",
"article-title": "Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic",
"author": "RD McBane",
"doi-asserted-by": "crossref",
"first-page": "2467",
"issue": "11",
"journal-title": "Mayo Clin Proc",
"key": "pone.0262348.ref043",
"volume": "95",
"year": "2020"
},
{
"DOI": "10.2478/jccm-2020-0033",
"article-title": "Anticoagulation in COVID—19: An Update.",
"author": "NR Tiwari",
"doi-asserted-by": "crossref",
"first-page": "217",
"issue": "4",
"journal-title": "J Crit Care Med (Targu Mures).",
"key": "pone.0262348.ref044",
"volume": "6",
"year": "2020"
},
{
"article-title": "Coronavirus disease 2019 (COVID-19): Hypercoagulability",
"author": "A Cuker",
"journal-title": "UpToDate.",
"key": "pone.0262348.ref045",
"year": "2020"
}
],
"reference-count": 45,
"references-count": 45,
"relation": {},
"score": 1,
"short-container-title": [
"PLoS ONE"
],
"short-title": [],
"source": "Crossref",
"subject": [
"Multidisciplinary"
],
"subtitle": [],
"title": [
"Prediction of mortality in hospitalized Egyptian patients with Coronavirus disease-2019: A multicenter retrospective study"
],
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1371/journal.pone.corrections_policy",
"volume": "17"
}